CoChat

Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class

Open access
Rapp, Micah, Guo, Yicheng, Reddem, Eswar R., Yu, Jian, Liu, Lihong, Wang, Pengfei, Cerutti, Gabriele, Katsamba, Phinikoula, Bimela, Jude S., Bahna, Fabiana A., Mannepalli, Seetha M., Zhang, Baoshan, Kwong, Peter D., Huang, Yaoxing, Ho, David D., Shapiro, Lawrence, Sheng, Zizhang · 2021 · Cell Reports

Published version of a preprint

Cited by 64

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

SUMMARY Antibodies with heavy chains that derive from the VH1-2 gene constitute some of the most potent SARS-CoV-2-neutralizing antibodies yet identified. To provide insight into whether these genetic similarities inform common modes of recognition, we determined structures of the SARS-CoV-2 spike in complex with three VH1-2-derived antibodies: 2-15, 2-43, and H4. All three utilized VH1-2-encoded motifs to recognize the receptor-binding domain (RBD), with heavy chain N53I enhancing binding and light chain tyrosines recognizing F486 RBD . Despite these similarities, class members bound both RBD-up and -down conformations of the spike, with a subset of antibodies utilizing elongated CDRH3s to recognize glycan N 343 on a neighboring RBD – a quaternary interaction accommodated by an increase in RBD separation of up to 12 Å. The VH1-2-antibody class thus utilizes modular recognition encoded by modular genetic elements to effect potent neutralization, with VH-gene component specifying recognition of RBD and CDRH3 component specifying quaternary interactions. Highlights Determine structures of VH1-2-derived antibodies 2-43, 2-15, and H4 in complex with SARS-CoV-2 spike Define a multi-donor VH1-2-antibody class with modular components for RBD and quaternary recognition Reveal structural basis of RBD-up and RBD-down recognition within the class Show somatic hypermutations and avidity to be critical for potency Delineate changes in spike conformation induced by CDRH3-mediated quaternary recognition

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2021.108950

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 56

  1. Adams, 2004, Recent developments in the PHENIX software for automated crystallographic structure determination, J. Synchrotron Radiat., 11, 53, 10.1107/S0909049503024130 · DOI · Paper page
  2. Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
  3. Bangaru, 2020, Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate, Science, 370, 1089, 10.1126/science.abe1502 · DOI · Paper page
  4. Brochet, 2008, IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis, Nucleic Acids Res., 36, 10.1093/nar/gkn316 · DOI · Paper page
  5. Cao, 2020, Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells, Cell, 182, 73, 10.1016/j.cell.2020.05.025 · DOI · Paper page
  6. Chen, 2010, MolProbity: all-atom structure validation for macromolecular crystallography, Acta Crystallogr. D Biol. Crystallogr., 66, 12, 10.1107/S0907444909042073 · DOI · Paper page
  7. 1994, The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr., 50, 760, 10.1107/S0907444994003112 · DOI · Paper page
  8. Croll, 2018, ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps, Acta Crystallogr. D Struct. Biol., 74, 519, 10.1107/S2059798318002425 · DOI · Paper page
  9. Davies, 2021, Estimated transmissibility and severity of novel SARS-CoV-2 variant of concern 202012/01 in England, medRxiv
  10. Davis, 2004, MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes, Nucleic Acids Res., 32, 10.1093/nar/gkh398 · DOI · Paper page
  11. Diemert, 2018, A phase I trial to evaluate the safety and immunogenicity of eOD-GT8 60mer vaccine, adjuvanted, ClinicalTrials.gov
  12. Dong, 2020, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect. Dis., 20, 533, 10.1016/S1473-3099(20)30120-1 · DOI · Paper page
  13. Du, 2020, Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy, Cell, 183, 1013, 10.1016/j.cell.2020.09.035 · DOI · Paper page
  14. Edgar, 2004, MUSCLE: multiple sequence alignment with high accuracy and high throughput, Nucleic Acids Res., 32, 1792, 10.1093/nar/gkh340 · DOI · Paper page
  15. Ehrhardt, 2019, Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV, Nat. Med., 25, 1589, 10.1038/s41591-019-0602-4 · DOI
  16. Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
  17. Emsley, 2010, Features and development of Coot, Acta Crystallogr. D Biol. Crystallogr., 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
  18. Evans, 2006, Scaling and assessment of data quality, Acta Crystallogr. D Biol. Crystallogr., 62, 72, 10.1107/S0907444905036693 · DOI · Paper page
  19. Haynes, 2012, B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study, Nat. Biotechnol., 30, 423, 10.1038/nbt.2197 · DOI · Paper page
  20. Henderson, 2020, Controlling the SARS-CoV-2 spike glycoprotein conformation, Nat. Struct. Mol. Biol., 27, 925, 10.1038/s41594-020-0479-4 · DOI · Paper page
  21. Herrera, 2020, Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis, ACS Omega, 6, 85, 10.1021/acsomega.0c03512 · DOI
  22. Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 · DOI · Paper page
  23. Huo, 2020, Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike, Cell Host Microbe, 28, 445, 10.1016/j.chom.2020.06.010 · DOI · Paper page
  24. Hurlburt, 2020, Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation, Nat. Commun., 11, 5413, 10.1038/s41467-020-19231-9 · DOI · Paper page
  25. Imkeller, 2018, Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope, Science, 360, 1358, 10.1126/science.aar5304 · DOI
  26. Joosten, 2014, The PDB_REDO server for macromolecular structure model optimization, IUCrJ, 1, 213, 10.1107/S2052252514009324 · DOI · Paper page
  27. Kabsch, 2010, Integration, scaling, space-group assignment and post-refinement, Acta Crystallogr. D Biol. Crystallogr., 66, 133, 10.1107/S0907444909047374 · DOI · Paper page
  28. Kallewaard, 2016, Structure and function analysis of an antibody recognizing all influenza A subtypes, Cell, 166, 596, 10.1016/j.cell.2016.05.073 · DOI · Paper page
  29. Kreer, 2020, Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients, Cell, 182, 843, 10.1016/j.cell.2020.06.044 · DOI · Paper page
  30. Krissinel, 2007, Inference of macromolecular assemblies from crystalline state, J. Mol. Biol., 372, 774, 10.1016/j.jmb.2007.05.022 · DOI · Paper page
  31. Kwong, 2012, Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies, Immunity, 37, 412, 10.1016/j.immuni.2012.08.012 · DOI · Paper page
  32. Kwong, 2018, HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure, Immunity, 48, 855, 10.1016/j.immuni.2018.04.029 · DOI · Paper page
  33. Lefranc, 2009, IMGT, the international ImMunoGeneTics information system, Nucleic Acids Res., 37, D1006, 10.1093/nar/gkn838 · DOI · Paper page
  34. Liu, 2020, Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity, Immunity, 53, 1272, 10.1016/j.immuni.2020.10.023 · DOI · Paper page
  35. Lv, 2020, Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody, Science, 369, 1505, 10.1126/science.abc5881 · DOI · Paper page
  36. McCallum, 2020, Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation, Nat. Struct. Mol. Biol., 27, 942, 10.1038/s41594-020-0483-8 · DOI · Paper page
  37. McCoy, 2007, Phaser crystallographic software, J. Appl. Cryst., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
  38. Pappas, 2014, Rapid development of broadly influenza neutralizing antibodies through redundant mutations, Nature, 516, 418, 10.1038/nature13764 · DOI · Paper page
  39. Pettersen, 2004, UCSF chimera—a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
  40. Punjani, 2017, cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination, Nat. Methods, 14, 290, 10.1038/nmeth.4169 · DOI · Paper page
  41. Schmidt, 2013, Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody, Proc. Natl. Acad. Sci. USA, 110, 264, 10.1073/pnas.1218256109 · DOI · Paper page
  42. Schramm, 2016, SONAR: a high-throughput pipeline for inferring antibody ontogenies from longitudinal sequencing of B cell transcripts, Front. Immunol., 7, 372, 10.3389/fimmu.2016.00372 · DOI · Paper page
  43. Suloway, 2005, Automated molecular microscopy: the new Leginon system, J. Struct. Biol., 151, 41, 10.1016/j.jsb.2005.03.010 · DOI · Paper page
  44. Toelzer, 2020, Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein, Science, 370, 725, 10.1126/science.abd3255 · DOI · Paper page
  45. Walls, 2020, Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058 · doi:10.1016/j.cell.2020.02.058 · Paper page
  46. Winn, 2011, Overview of the CCP4 suite and current developments, Acta Crystallogr. D Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 · DOI · Paper page
  47. Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507 · DOI · Paper page
  48. Wu, 2020, An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain, Cell Rep., 33, 108274, 10.1016/j.celrep.2020.108274 · DOI · Paper page
  49. Wu, 2020, A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2, Science, 368, 1274, 10.1126/science.abc2241 · DOI · Paper page
  50. Yao, 2021, Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection, Cell Res., 31, 25, 10.1038/s41422-020-00444-y · DOI
  51. Ye, 2013, IgBLAST: an immunoglobulin variable domain sequence analysis tool, Nucleic Acids Res., 41, 10.1093/nar/gkt382 · DOI · Paper page
  52. Zhou, 2013, Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies, Immunity, 39, 245, 10.1016/j.immuni.2013.04.012 · DOI · Paper page
  53. Zhou, 2015, Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors, Cell, 161, 1280, 10.1016/j.cell.2015.05.007 · DOI · Paper page
  54. Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page
  55. Zhu, 2014, Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction, Proteins, 82, 1646, 10.1002/prot.24551 · DOI · Paper page
  56. Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 · DOI · Paper page

Cited by

Metadata

Authors
Rapp, M., Guo, Y., Reddem, E. R., Yu, J., Liu, L., Wang, P., Cerutti, G., Katsamba, P., Bimela, J. S., Bahna, F. A., Mannepalli, S. M., Zhang, B., Kwong, P. D., Huang, Y., Ho, D. D., Shapiro, L., & Sheng, Z.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2021-04
Volume
35
Issue
1
Pages
108950
ISSN
2211-1247 (ISSN-L)
OpenAlex
W3136200177
Cited by
64
References
34
FWCI
3.70
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.